• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular Determinants of the Differential Modulation of Ca1.2 and Ca1.3 by Nifedipine and FPL 64176.硝苯地平和 FPL 64176 对 Ca1.2 和 Ca1.3 调节作用差异的分子决定因素。
Mol Pharmacol. 2018 Sep;94(3):973-983. doi: 10.1124/mol.118.112441. Epub 2018 Jul 6.
2
Voltage-gated divalent currents in descending vasa recta pericytes.降支直小血管周细胞的电压门控二价电流。
Am J Physiol Renal Physiol. 2010 Oct;299(4):F862-71. doi: 10.1152/ajprenal.00321.2010. Epub 2010 Jul 14.
3
Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.苯丙氨酸1112和丝氨酸1115在L型钙通道α1C亚基(CaV 1.2)的成孔IIIS5-S6连接子中在二氢吡啶结合及钙通道激动剂作用方面的关键作用。
Mol Pharmacol. 2003 Aug;64(2):235-48. doi: 10.1124/mol.64.2.235.
4
Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts.钙离子通道激动剂FPL-64716对Langendorff灌流小鼠心脏的致心律失常作用。
Exp Physiol. 2009 Feb;94(2):240-54. doi: 10.1113/expphysiol.2008.044669. Epub 2008 Oct 31.
5
Physiological and pharmacological modulation of the embryonic skeletal muscle calcium channel splice variant CaV1.1e.胚胎骨骼肌钙通道剪接变体CaV1.1e的生理和药理调节
Biophys J. 2015 Mar 10;108(5):1072-80. doi: 10.1016/j.bpj.2015.01.026.
6
Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.氨氯地平和尼卡地平对电压依赖性钙通道 Cav1.2 和 Cav2.1 以及突变通道 Cav1.2/二氢吡啶不敏感和 Cav2.1/二氢吡啶敏感的阻断作用具有不同的特性。
Eur J Pharmacol. 2011 Nov 16;670(1):105-13. doi: 10.1016/j.ejphar.2011.08.005. Epub 2011 Sep 2.
7
Dihydropyridine receptors and type 1 ryanodine receptors constitute the molecular machinery for voltage-induced Ca2+ release in nerve terminals.二氢吡啶受体和1型兰尼碱受体构成了神经末梢中电压诱导的Ca2+释放的分子机制。
J Neurosci. 2006 Jul 19;26(29):7565-74. doi: 10.1523/JNEUROSCI.1512-06.2006.
8
Direct Estimation of CaV1.2 Gating Parameters: Quantification of Voltage Sensor - Pore Transductions and their Modulation by FLP 64176.CaV1.2门控参数的直接估计:电压传感器-孔转导的量化及其受FLP 64176的调节
Curr Mol Pharmacol. 2015;8(1):87-94. doi: 10.2174/1874467208666150507100256.
9
The calcium channel ligand FPL 64176 enhances L-type but inhibits N-type neuronal calcium currents.钙通道配体FPL 64176增强L型但抑制N型神经元钙电流。
Neuropharmacology. 2003 Aug;45(2):281-92. doi: 10.1016/s0028-3908(03)00153-9.
10
Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists.L型Ca2+通道α1C亚基IIIS5-S6连接区中的丝氨酸残基是二氢吡啶Ca2+通道激动剂作用的关键决定因素。
J Biol Chem. 2000 Dec 29;275(52):41504-11. doi: 10.1074/jbc.M007165200.

引用本文的文献

1
The L-type calcium channel CaV1.3: A potential target for cancer therapy.L 型钙通道 Cav1.3:癌症治疗的潜在靶点。
J Cell Mol Med. 2024 Oct;28(19):e70123. doi: 10.1111/jcmm.70123.
2
Mechanism of gabapentinoid potentiation of opioid effects on cyclic AMP signaling in neuropathic pain.加巴喷丁类药物增强阿片类药物对神经病理性疼痛中环腺苷酸信号作用的机制。
Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2405465121. doi: 10.1073/pnas.2405465121. Epub 2024 Aug 15.
3
Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs.心肌切片检测猪心毒性的收缩力测量
Cardiovasc Res. 2023 Nov 15;119(14):2469-2481. doi: 10.1093/cvr/cvad141.
4
Investigations into hydrogen sulfide-induced suppression of neuronal activity in vivo and calcium dysregulation in vitro.硫化氢诱导的体内神经元活动抑制及体外钙调节异常的研究。
Toxicol Sci. 2023 Mar 6;192(2):247-64. doi: 10.1093/toxsci/kfad022.
5
Ca 1.3-selective inhibitors of voltage-gated L-type Ca channels: Fact or (still) fiction?电压门控 L 型钙通道的 Ca1.3 选择性抑制剂:事实还是虚构?
Br J Pharmacol. 2023 May;180(10):1289-1303. doi: 10.1111/bph.16060. Epub 2023 Mar 14.
6
How filopodia respond to calcium in the absence of a calcium-binding structural protein: non-channel functions of TRP.在没有钙结合结构蛋白的情况下,丝状伪足如何对钙作出反应:TRP 的非通道功能。
Cell Commun Signal. 2022 Aug 26;20(1):130. doi: 10.1186/s12964-022-00927-y.
7
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects.抗高血压药物与大脑功能:治疗有益和有害神经精神作用的潜在机制。
Cardiovasc Res. 2023 May 2;119(3):647-667. doi: 10.1093/cvr/cvac110.
8
A Sea Anemone Venom Fraction Decreases Boar Sperm Cells Capacitation: Possible Involvement of HVA Calcium Channels.海葵毒液组分可降低公猪精子获能:可能涉及 HVA 钙通道。
Toxins (Basel). 2022 Apr 7;14(4):261. doi: 10.3390/toxins14040261.
9
Small Molecules as Modulators of Voltage-Gated Calcium Channels in Neurological Disorders: State of the Art and Perspectives.小分子作为神经紊乱中电压门控钙通道调节剂的研究进展与展望
Molecules. 2022 Feb 15;27(4):1312. doi: 10.3390/molecules27041312.
10
Protective effects of calcium ions via L-type calcium channels and NMDA receptors on prostaglandin E-induced apoptosis in rat cortical cells.钙离子通过 L 型钙通道和 NMDA 受体对前列腺素 E 诱导的大鼠皮质细胞凋亡的保护作用。
Mol Biol Rep. 2021 May;48(5):4517-4525. doi: 10.1007/s11033-021-06472-0. Epub 2021 Jun 5.

本文引用的文献

1
SWISS-MODEL: homology modelling of protein structures and complexes.SWISS-MODEL:蛋白质结构和复合物的同源建模。
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303. doi: 10.1093/nar/gky427.
2
Modeling protein quaternary structure of homo- and hetero-oligomers beyond binary interactions by homology.通过同源建模来模拟同聚体和异聚体的蛋白质四级结构,超越二元相互作用。
Sci Rep. 2017 Sep 5;7(1):10480. doi: 10.1038/s41598-017-09654-8.
3
The SWISS-MODEL Repository-new features and functionality.SWISS-MODEL资源库——新特性与功能
Nucleic Acids Res. 2017 Jan 4;45(D1):D313-D319. doi: 10.1093/nar/gkw1132. Epub 2016 Nov 29.
4
Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 Å resolution.电压门控钙通道 Ca(v)1.1 的 3.6Å 分辨率结构。
Nature. 2016 Sep 8;537(7619):191-196. doi: 10.1038/nature19321. Epub 2016 Aug 31.
5
Modest CaV1.342-selective inhibition by compound 8 is β-subunit dependent.化合物8对CaV1.3 42亚基的适度抑制作用依赖于β亚基。
Nat Commun. 2014 Jul 24;5:4481. doi: 10.1038/ncomms5481.
6
Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators.嘧啶-2,4,6-三酮是一类新型的电压门控L型钙离子通道激活剂。
Nat Commun. 2014 Jun 19;5:3897. doi: 10.1038/ncomms4897.
7
New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury.具有改善的CaV1.3选择性的新型5-未取代二氢吡啶作为针对缺血性损伤的潜在神经保护剂。
J Med Chem. 2014 May 22;57(10):4313-23. doi: 10.1021/jm500263v. Epub 2014 May 7.
8
C-terminal alternative splicing of CaV1.3 channels distinctively modulates their dihydropyridine sensitivity.C 端可变剪接显著调节 Cav1.3 通道对二氢吡啶的敏感性。
Mol Pharmacol. 2013 Oct;84(4):643-53. doi: 10.1124/mol.113.087155. Epub 2013 Aug 7.
9
Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.N,N'-二取代嘧啶并三酮作为帕金森病 Ca(V)1.3 钙通道选择性拮抗剂的构效关系。
J Med Chem. 2013 Jun 13;56(11):4786-97. doi: 10.1021/jm4005048. Epub 2013 May 23.
10
In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells.在 1 型糖尿病中,柯萨奇 B4 病毒抗体的亚群可识别自身抗原并诱导胰岛β细胞凋亡。
PLoS One. 2013;8(2):e57729. doi: 10.1371/journal.pone.0057729. Epub 2013 Feb 28.

硝苯地平和 FPL 64176 对 Ca1.2 和 Ca1.3 调节作用差异的分子决定因素。

Molecular Determinants of the Differential Modulation of Ca1.2 and Ca1.3 by Nifedipine and FPL 64176.

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University College of Pharmacy, West Lafayette, Indiana.

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University College of Pharmacy, West Lafayette, Indiana

出版信息

Mol Pharmacol. 2018 Sep;94(3):973-983. doi: 10.1124/mol.118.112441. Epub 2018 Jul 6.

DOI:10.1124/mol.118.112441
PMID:29980657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11033928/
Abstract

Nifedipine and FPL 64176 (FPL), which block and potentiate L-type voltage-gated Ca channels, respectively, modulate Ca1.2 more potently than Ca1.3. To identify potential strategies for developing subtype-selective inhibitors, we investigated the role of divergent amino acid residues in transmembrane domains IIIS5 and the extracellular IIIS5-3P loop region in modulation of these channels by nifedipine and FPL. Insertion of the extracellular IIIS5-3P loop from Ca1.2 into Ca1.3 (Ca1.3+) reduced the IC of nifedipine from 289 to 101 nM, and substitution of S1100 with an A residue, as in Ca1.2, accounted for this difference. Substituting M1030 in IIIS5 to V in Ca1.3+ (Ca1.3+V) further reduced the IC of nifedipine to 42 nM. FPL increased current amplitude with an EC of 854 nM in Ca1.3, 103 nM in Ca1.2, and 99 nM in Ca1.3+V. In contrast to nifedipine block, substitution of M1030 to V in Ca1.3 had no effect on potency of FPL potentiation of current amplitude, but slowed deactivation in the presence and absence of 10 M FPL. FPL had no effect on deactivation of Ca1.3/dihydropyridine-insensitive (DHPi), a channel with very low sensitivity to nifedipine block (IC ∼93 M), but did shift the voltage-dependence of activation by ∼-10 mV. We conclude that the M/V variation in IIIS5 and the S/A variation in the IIIS5-3P loop of Ca1.2 and Ca1.3 largely determine the difference in nifedipine potency between these two channels, but the difference in FPL potency is determined by divergent amino acids in the IIIS5-3P loop.

摘要

硝苯地平和 FPL 64176(FPL)分别阻断和增强 L 型电压门控钙通道,对 Ca1.2 的调制作用强于 Ca1.3。为了确定开发亚型选择性抑制剂的潜在策略,我们研究了跨膜结构域 IIIS5 和细胞外 IIIS5-3P 环区域中发散氨基酸残基在硝苯地平和 FPL 对这些通道的调制中的作用。将 Ca1.2 的细胞外 IIIS5-3P 环插入 Ca1.3(Ca1.3+)中,将硝苯地平的 IC 从 289 降低到 101 nM,而 S1100 被 A 残基取代,如 Ca1.2 中的那样,解释了这种差异。将 IIIS5 中的 M1030 替换为 Ca1.3+中的 V(Ca1.3+V)进一步将硝苯地平的 IC 降低至 42 nM。FPL 在 Ca1.3 中增加电流幅度的 EC 为 854 nM,在 Ca1.2 中为 103 nM,在 Ca1.3+V 中为 99 nM。与硝苯地平阻断相反,在 Ca1.3 中,M1030 取代 V 对 FPL 增强电流幅度的效力没有影响,但在存在和不存在 10 M FPL 的情况下,使失活速度变慢。FPL 对 Ca1.3/二氢吡啶不敏感(DHPi)的失活没有影响,该通道对硝苯地平阻断的敏感性非常低(IC∼93 M),但确实将激活的电压依赖性移动了约-10 mV。我们得出结论,Ca1.2 和 Ca1.3 中 IIIS5 的 MV 变化和 IIIS5-3P 环中的 SA 变化在这两个通道之间的硝苯地平效力差异中起主要作用,但 FPL 效力的差异取决于 IIIS5-3P 环中的发散氨基酸。